期刊文献+

内皮素-1基因Lys198Asn多态性与室间隔缺损肺动脉高压相关性 被引量:2

Association between endothelin-1 gene Lys198Asn polymorphism and ventricular septal defects related pulmonary arterial hypertension
在线阅读 下载PDF
导出
摘要 目的:研究室间隔缺损(室缺)人群中内皮素-1基因Lys198Asn多态性与其发生肺动脉高压的相关性,寻找新的室缺肺动脉高压形成的危险因素。方法:采用以医院为基础的病例-对照研究方法,以PCR-RFLP技术分析140例室缺肺动脉高压病例和140例非肺动脉高压室缺对照内皮素-1基因Lys198Asn多态性,比较不同基因型与肺动脉高压形成危险因素关系。结果:①肺动脉高压组Lys198Asn GT和TT基因型频率明显高于非肺动脉高压组(43.6%vs 33.6%,10.7%vs 3.6%),差异有显著意义(χ2=5.23,校正OR=1.78,P<0.05;χ2=7.70,校正OR=3.34,P<0.01);②肺动脉高压组GT+TT基因型频率明显高于非肺动脉高压组(54.3%vs 37.2%),差异有显著意义(χ2=8.29,校正OR=1.94,P<0.01);③肺动脉高压组T等位基因频率明显高于非肺动脉高压组(32.5%vs 20.4%),差异有显著意义(χ2=10.62,P<0.01)。结论:内皮素-1基因Lys198Asn多态性与室缺肺动脉高压形成相关,可能是其形成的危险因素之一。 Objective:To investigate the correlation between polymorphism of Lys198Asn of endothelin(ET)-1 gene exon 5 and ventricular septal defects(VSD) related pulmonary arterial hypertension(PAH),and risk factors of PAH.Methods:Genotypes were determined by the PCR-restriction fragment length polymorphism(PCR-RFLP) method in 140 VSD related PAH cases and 140 non-PAH controls.Results:①The frequencies of GT and TT genotypes in PAH group were significantly higher than non-PAH group(43.6% vs 33.6%,adjusted OR=1.78,P 〈 0.05;10.7% vs 3.6%,adjusted OR=3.34,P 〈 0.01;respectively);②The frequency of GT+TT genotypes in PAH group was significantly higher than that of the controls(54.3% vs 37.2%,adjusted OR=1.94,P 〈 0.01);③The T allele frequency in PAH group was significantly higher than that in the controls(32.5% vs 20.4%,P 〈 0.01).Conclusion: ET-1 gene Lys198Asn polymorphism is associated with and may be a new risk factor of PAH.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2011年第3期335-338,355,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金(30876324) 江苏省自然科学基金(BK2006248) 教育部博士点基金(303070534HA10)
关键词 内皮素-1 Lys198Asn 室间隔缺损 肺动脉高压 多态性 Endothelin-1 Lys198Asn ventricular septal defects pulmonary arterial hypertension polymorphism
作者简介 通讯作者,E-mail:YJChen@njmu.edu.cn
  • 相关文献

参考文献15

  • 1Moller T, Leren TP, Eiklid KL, et al. A novel BMPR2 gene mutation associated with exercise-induced pulmonary hypertension in septal defects [J]. Scand Cardiovasc J,2010,44(6) :331-336.
  • 2沈红,解卫平,王虹,金宇,蔡健康.埃他卡林对低氧性肺动脉高压大鼠内皮素受体mRNA表达的影响[J].南京医科大学学报(自然科学版),2009,29(5):691-694. 被引量:1
  • 3Barden AE, Herbison CE, Beilin LJ, et al. Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy [J]. J Hyperten,2001,19 (10) : 1775-1782.
  • 4Duffels MG, Engelfriet PM, Berger RM, et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry [J]. Int J Cardiol, 2007,120(2) : 198-204.
  • 5Lefebvre MC, Hunsche E. Oral Therapies for the treatment of pulmonary arterial hypertension: a population- based cost-minimization analysis [J]. Appl Health Econ Health Policy, 2010,8 (1) : 69-71.
  • 6Takahashi H, Soma S, Muramatsu M, et al. Discrepant distribution of big endothelin (ET)-I and ET receptors in the pulmonary artery [ J ]. Eur Respir J, 2001,18 (1) : 5 - 14.
  • 7Harada-Shiba M, Takamisawa I, Miyata K, et al. Intratracheal gene transfer of adrenomedullin using polyplex nanomicelles attenuates monocrotaline-induced pulmonary hypertension in rats [J].Mol Ther,2009,17 (7) : 1180- 1186.
  • 8Yamanaka R, Otsuka F, Nakamura K, et al. Involvement of the bone morphogenetic protein system in endothelin and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension [J].Hypertens Res, 2010,33(5) :435-445.
  • 9Yoshibayashi M, Nishioka K, Nakao K, et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation[J]. Circulation, 1991,84(6) :2280-2285.
  • 10Treiber FA, Barbeau P, Harshfield G,et al. Endothelin- 1 gene LYS198ASN polymorphism and blood pressure reactivity[J]. Hypertension,2003,42(4) :494-499.

二级参考文献42

  • 1Attina T,Camidge R,Newby DE,et al. Endothelin antagonism in pulmonary hypertension, heart failure, and beyond [ J ]. Heart, 2005,91 : 825-831.
  • 2Lee SH,Channick RN. Endothelin antagonism in pulmonary arterial hypertension [J]. Seminars in Respir and Crit Care Med, 2005,26 (4) :402--408.
  • 3Ko EA,Han J,Jung ID,et al. Physiological roles of K+ channels in vascular smooth muscle cells [J]. Smooth Muscle Res, 2008,44 (2) : 65 -81.
  • 4Zhu YM,Zhang SJ,Xie WP, et al. Iptakalim inhibited edothelin-1-induced proliferation of human pulmonary arterial smooth muscle cells through the activation of KATP channel[ J ]. Vasc Pharmacol, 2008,48 : 92-99.
  • 5Xie WP,Wang Hb,Wang H,et al. Effects of iptakalim hydrochloride, a novel KATP channel opener, on pulmonary vascular remodeling in hypoxic rats [J]. Life Sci, 2004,75 : 2065-2076.
  • 6Perros F, Dorfmuller P, Humbert M. Current Insights on the Pathogenesis of Pulmonary Arterial Hypertension[J]. Seminars in Respir and Crit Care Med,2005,26(4) :355-364.
  • 7Mandegar M,Yuan JXJ. Role of K^+ channels in pulmonary hypertension [ J ]. Vascular Pharmocol, 2002,38 : 25-33.
  • 8Wang H,Tang Y,Zhang YL. Hypoxic pulmonary hypertension(HPH)and iptakalim,a novel ATP-sensitive potassium channel opener targeting smaller arteries in hypertension[J]. Cardiovasc Drug,2005,23(4) :293-316.
  • 9Galie' N,Manes A,Branzi A. The endothelin system in pulmonary arterial hypertension [J]. Cardiovasc Res, 2004,61 : 227-237.
  • 10Michel RP, Langleben D, Dupuis J. The endothelin system in pulmonary hypertension [J]. Can J Physiol Pharmacol, 2003,81 : 542-554.

共引文献12

同被引文献23

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部